comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.
alpha d3 0,5 mikrograma mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 0,5 µg / 1 kapsula - alfakalcidol (kalcidiol)
alpha d3 1 mikrogram mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 1 µg / 1 kapsula - alfakalcidol (kalcidiol)
alpha d3 0,25 mikrograma mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 0,25 µg / 1 kapsula - alfakalcidol (kalcidiol)
alpha d3 1 mikrogram mehke kapsule
teva pharma b.v. - alfakalcidol - kapsula, mehka - alfakalcidol 1 mg / 1 kapsula - alfakalcidol (kalcidiol)
bcg-medac prašek in vehikel za suspenzijo za intravezikalno uporabo
medac gmbh - vehikel - prašek in vehikel za intravezikalno suspenzijo - vehikel 50 ml / 1 viala - bcg cepivo proti tuberkulozi
bcg-medac prašek in vehikel za suspenzijo za intravezikalno uporabo
medac gmbh - sev rivm bakterije bcg (bacillus calmette-guérin) pridobljenega iz seva 1173-p2 - prašek in vehikel za intravezikalno suspenzijo - sev rivm bakterije bcg (bacillus calmette-guérin) pridobljenega iz seva 1173-p2 3000000000 cfu / 1 viala - bcg cepivo proti tuberkulozi
bcg-medac prašek in vehikel za suspenzijo za intravezikalno uporabo
medac gmbh - sev rivm bakterije bcg (bacillus calmette-guérin) pridobljenega iz seva 1173-p2 - prašek in vehikel za intravezikalno suspenzijo - sev rivm bakterije bcg (bacillus calmette-guérin) pridobljenega iz seva 1173-p2 3000000000 cfu / 1 viala - bcg cepivo proti tuberkulozi
kybernin p 500 i.e. prašek in vehikel za raztopino za injiciranje/infundiranje
csl behring gmbh - antitrombin - prašek in vehikel za raztopino za injiciranje/infundiranje - antitrombin 500 i.e. / 1 viala - antitrombin
airflusan forspiro 50 mikrogramov/500 mikrogramov/odmerek prašek za inhaliranje, odmerjeni
lek d.d. - flutikazonpropionat; salmeterol - prašek za inhaliranje, odmerjeni - flutikazonpropionat 500 µg / 1 odmerek salmeterol50 µg / 1 odmerek; salmeterol 50 µg / 1 odmerek - salmeterol in flutikazon